Walmart agrees to pay $50m to settle DOJ opioid-dispensing allegations

Shivam Mishra Mon, August 31, 2026 at 2:00 AM PDT 2 min read

Walmart has agreed to pay $50 million to resolve U.S. government allegations that its pharmacies knowingly filled thousands of invalid opioid and other controlled-substance prescriptions.

The settlement addresses alleged violations of the Controlled Substances Act dating from June 2013.

DOJ Allegations

The Department of Justice (DOJ) complaint, filed in December 2020 and amended in 2022 in the U.S. District Court for the District of Delaware, alleged that:

• Walmart's compliance personnel knew certain prescribers were operating "pill mills" but allowed prescriptions from them to be filled.
• Walmart pharmacists filled prescriptions with apparent warning signs, including dangerous drug combinations, repeated high-dose opioid prescriptions, and early refill requests.
• Pharmacists raised concerns through thousands of "refusal-to-fill" reports.
• Walmart's compliance team prioritized other business objectives instead of investigating those reports.
• One compliance director allegedly described "driving sales and patient awareness" as a better use of management time than analyzing the reports.

Regulatory Response

Drug Enforcement Administration (DEA) Assistant Administrator Cheri Oz stated:

"Filling illegitimate opioid prescriptions puts patients and communities at risk and undermines the safeguards designed to prevent the diversion and misuse of potentially addictive medications. This settlement addresses past conduct while establishing clear compliance obligations designed to strengthen safeguards and help prevent these failures from happening again."

Settlement Terms

Walmart has also signed a memorandum of agreement with the DEA. Under the terms, the company must:

• Establish a hotline for employees and patients to report suspected illegal dispensing.
• Monitor pharmacy dispensing patterns.
• Create a process for reviewing prescribers suspected of unlawful prescribing.

Associate Attorney General Stanley Woodward said the department would enforce pharmacies' obligations, "ensuring that potential profits never justify aiding our Nation's opioid epidemic."

Walmart's Response

Walmart stated in a regulatory disclosure that it settled the case without admitting liability and had accrued an "immaterial" amount as of July 31, 2026.

The settlement comes as Walmart reported second-quarter net sales of $186.10 billion, up 5.9% year on year, and raised its fiscal 2027 guidance.

"Walmart to pay $50m to settle DOJ opioid-dispensing allegations" was originally created and published by Retail Insight Network, a GlobalData owned brand.